MUSCLE RELAXANT AND ANALGESIC CAPLETS TABLET
Land: Kanada
Språk: engelska
Källa: Health Canada
Produktens egenskaper
(SPC)
01-02-2010
Vissa dokument för denna produkt är för närvarande inte tillgängliga, du kan skicka en begäran till vår kundservice och vi kommer att meddela dig så snart vi kan få dem.
Skicka förfrågan.
Skicka förfrågan.
Aktiva substanser:
IBUPROFEN; METHOCARBAMOL
Tillgänglig från:
INTERNATIONAL PHARMACEUTICAL GENERICS LTD
ATC-kod:
M03BA53
INN (International namn):
METHOCARBAMOL, COMBINATIONS EXCL PSYCHOLEPTICS
Dos:
200MG; 500MG
Läkemedelsform:
TABLET
Sammansättning:
IBUPROFEN 200MG; METHOCARBAMOL 500MG
Administreringssätt:
ORAL
Enheter i paketet:
100
Receptbelagda typ:
OTC
Terapiområde:
CENTRALLY ACTING SKELETAL MUSCLE RELAXANTS
Produktsammanfattning:
Active ingredient group (AIG) number: 0248961001; AHFS:
Bemyndigande status:
CANCELLED PRE MARKET
Tillstånd datum:
2017-06-13
Produktens egenskaper
1 | P a g e
PRODUCT MONOGRAPH
MUSCLE RELAXANT & ANALGESIC CAPLETS
500 MG METHOCARBAMOL AND 200 MG IBUPROFEN TABLETS
THERAPEUTIC CLASSIFICATION
MUSCLE RELAXANT / ANALGESIC
INTERNATIONAL PHARMACEUTICAL GENERICS LTD.,
Date of Preparation:
30 Malta Avenue, Suite 2408
February 01, 2010
Brampton, ON
L6Y 4S5
Control#: 135919
2 | P a g e
TABLE
OF CONTENTS
Clinical
Pharmacology..............................................................................................................................3
Indications:................................................................................................................................................7
Contraindications
......................................................................................................................................8
Warnings:..................................................................................................................................................8
Precautions..............................................................................................................................................12
Drug Interactions
....................................................................................................................................13
Adverse Reactions
..................................................................................................................................15
Symptoms and Treatment of
Overdose...................................................................................................17
Dosage and
Administration.....................................................................................................................18
Pharmaceutical
Information....................................................................................................................19
Composition:...........................................................................................................................................21
Availability of Dosage
Forms............
Läs hela dokumentet
